vs
Side-by-side financial comparison of BioLineRx Ltd. (BLRX) and INTELLIGENT PROTECTION MANAGEMENT CORP. (IPM). Click either name above to swap in a different company.
INTELLIGENT PROTECTION MANAGEMENT CORP. is the larger business by last-quarter revenue ($6.1M vs $5.4M, roughly 1.1× BioLineRx Ltd.).
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange.
Intelligent Limited is a Holding Company and Parent company headquartered in Gloucestershire, United Kingdom and was incorporated on 21 May 2008. Intelligent Limited provides a group management structure for four companies and was born out of the operations of International Intelligence Limited, a company specialising in Intelligence, Counter Espionage and TSCM sweeping.
BLRX vs IPM — Head-to-Head
Income Statement — Q2 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.4M | $6.1M |
| Net Profit | $484.0K | — |
| Gross Margin | 83.4% | 53.1% |
| Operating Margin | -107.0% | -13.4% |
| Net Margin | 9.0% | — |
| Revenue YoY | — | 2091.6% |
| Net Profit YoY | 102.6% | — |
| EPS (diluted) | $0.00 | $-0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $6.1M | ||
| Q3 25 | — | $6.2M | ||
| Q2 25 | — | $5.7M | ||
| Q1 25 | — | $5.5M | ||
| Q2 24 | $5.4M | — | ||
| Q4 23 | — | $-7.3M | ||
| Q3 23 | — | $2.8M | ||
| Q2 23 | $0 | $3.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-1.1M | ||
| Q2 25 | — | $-1.1M | ||
| Q1 25 | — | $808.5K | ||
| Q2 24 | $484.0K | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | $-181.6K | ||
| Q2 23 | $-18.5M | $135.6K |
| Q4 25 | — | 53.1% | ||
| Q3 25 | — | 50.7% | ||
| Q2 25 | — | 50.1% | ||
| Q1 25 | — | 55.3% | ||
| Q2 24 | 83.4% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | 70.1% | ||
| Q2 23 | — | 73.8% |
| Q4 25 | — | -13.4% | ||
| Q3 25 | — | -23.0% | ||
| Q2 25 | — | -19.7% | ||
| Q1 25 | — | -24.2% | ||
| Q2 24 | -107.0% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | -14.1% | ||
| Q2 23 | — | -9.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | -17.4% | ||
| Q2 25 | — | -18.3% | ||
| Q1 25 | — | 14.7% | ||
| Q2 24 | 9.0% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | -6.6% | ||
| Q2 23 | — | 4.6% |
| Q4 25 | — | $-0.05 | ||
| Q3 25 | — | $-0.08 | ||
| Q2 25 | — | $-0.08 | ||
| Q1 25 | — | $0.06 | ||
| Q2 24 | $0.00 | — | ||
| Q4 23 | — | $-0.03 | ||
| Q3 23 | — | $-0.02 | ||
| Q2 23 | $-0.02 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $9.6M | $5.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $13.9M | $18.2M |
| Total Assets | $64.6M | $26.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.6M | ||
| Q3 25 | — | $7.3M | ||
| Q2 25 | — | $7.3M | ||
| Q1 25 | — | $9.7M | ||
| Q2 24 | $9.6M | — | ||
| Q4 23 | — | $13.6M | ||
| Q3 23 | — | $13.7M | ||
| Q2 23 | $10.1M | $13.7M |
| Q4 25 | — | $18.2M | ||
| Q3 25 | — | $18.8M | ||
| Q2 25 | — | $19.9M | ||
| Q1 25 | — | $21.1M | ||
| Q2 24 | $13.9M | — | ||
| Q4 23 | — | $20.1M | ||
| Q3 23 | — | $20.4M | ||
| Q2 23 | $21.1M | $20.5M |
| Q4 25 | — | $26.0M | ||
| Q3 25 | — | $27.2M | ||
| Q2 25 | — | $29.8M | ||
| Q1 25 | — | $31.1M | ||
| Q2 24 | $64.6M | — | ||
| Q4 23 | — | $23.9M | ||
| Q3 23 | — | $24.1M | ||
| Q2 23 | $58.9M | $24.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.4M | $87.6K |
| Free Cash FlowOCF − Capex | $-25.5M | — |
| FCF MarginFCF / Revenue | -472.8% | — |
| Capex IntensityCapex / Revenue | 1.1% | — |
| Cash ConversionOCF / Net Profit | -52.56× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $87.6K | ||
| Q3 25 | — | $133.0K | ||
| Q2 25 | — | $-888.7K | ||
| Q1 25 | — | $1.7M | ||
| Q2 24 | $-25.4M | — | ||
| Q4 23 | — | $-99.0K | ||
| Q3 23 | — | $16.1K | ||
| Q2 23 | $-17.7M | $-193.8K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | $-25.5M | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | $-17.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | -472.8% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | 1.1% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.16× | ||
| Q2 24 | -52.56× | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | -1.43× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLRX
Segment breakdown not available.
IPM
| Procurement Revenue | $5.4M | 88% |
| Other | $743.9K | 12% |
